Paper42042001
Saturation Genome Editing Targeting KRAS Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model.
Hamada T and 9 others. Curr Issues Mol Biol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Saturation Genome Editing Targeting KRAS Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model. Papers, record 42042001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42042001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Saturation Genome Editing Targeting KRAS Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP22H04925 (PAGS) | Japan Society for the Promotion of Science | PubMed | ||
| JP25K10541 | Japan Society for the Promotion of Science | PubMed | ||
| N/A | Kagoshima University Megumikai Medical Research Promotion Fund | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38836089 | Reducing uncertainty in genetic testing with Saturation Genome Editing. | Med Genet | 2022 | https://conductscience.org/library/papers/38836089 | PubMed |
| 2 | 38613907 | Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases. | ESMO Open | 2024 | https://conductscience.org/library/papers/38613907 | PubMed |
| 3 | 36316602 | Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. | Cancer Commun (Lond) | 2023 | https://conductscience.org/library/papers/36316602 | PubMed |
| 4 | 40365399 | Genetic Variation in Drug Targets: Are We Ready for the Era of Precision Medicinal Chemistry? | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/40365399 | PubMed |
| 5 | 28890946 | OncoKB: A Precision Oncology Knowledge Base. | JCO Precis Oncol | 2017 | https://conductscience.org/library/papers/28890946 | PubMed |
| 6 | 26472760 | Gene essentiality and synthetic lethality in haploid human cells. | Science | 2015 | https://conductscience.org/library/papers/26472760 | PubMed |
| 7 | 33202260 | Multiplexed Functional Assessment of Genetic Variants in CARD11. | Am J Hum Genet | 2020 | https://conductscience.org/library/papers/33202260 | PubMed |
| 8 | 30809026 | CRISPResso2 provides accurate and rapid genome editing sequence analysis. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/30809026 | PubMed |
| 9 | 38969834 | Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. | Nat Genet | 2024 | https://conductscience.org/library/papers/38969834 | PubMed |
| 10 | 38057330 | Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation. | Nat Commun | 2023 | https://conductscience.org/library/papers/38057330 | PubMed |
| 11 | 36613947 | Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613947 | PubMed |
| 12 | 30371878 | COSMIC: the Catalogue Of Somatic Mutations In Cancer. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371878 | PubMed |
| 13 | 39468210 | The present and future of the Cancer Dependency Map. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/39468210 | PubMed |
| 14 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 15 | 31972237 | Precision Therapy in RAS Mutant Colorectal Cancer. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31972237 | PubMed |
| 16 | 37713444 | Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. | PLoS Genet | 2023 | https://conductscience.org/library/papers/37713444 | PubMed |
| 17 | 25141179 | Saturation editing of genomic regions by multiplex homology-directed repair. | Nature | 2014 | https://conductscience.org/library/papers/25141179 | PubMed |
| 18 | 38682594 | SynDesign: web-based prime editing guide RNA design and evaluation tool for saturation genome editing. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/38682594 | PubMed |
| 19 | 39779848 | Saturation genome editing-based clinical classification of BRCA2 variants. | Nature | 2025 | https://conductscience.org/library/papers/39779848 | PubMed |
| 20 | 39299233 | High-resolution functional mapping of RAD51C by saturation genome editing. | Cell | 2024 | https://conductscience.org/library/papers/39299233 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42042001
GET https://conductscience.org/api/papers/v1/42042001/references?page=2